Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Venous Thrombosis in Behçet's Disease
NCT06925698Phase 3Not yet recruiting
- Sponsor
- Marmara University
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in venous thrombosis, sponsored by Marmara University. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
rivaroxaban
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT06925698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06925698.